Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
PHASE1
This phase I trial tests the safety, side effects, and best dose of ZEN0036...
A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma.
PHASE2
This study intends to enroll patients with advanced soft tissue sarcoma, em...
Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer
NA
Radiation therapy is a crucial part in the comprehensive treatment of breas...
Status
Recruiting
Location
Cancer Hospital ,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
PHASE1
This is a phase I-II trial to find the safety and activity of adding a new ...
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
PHASE3
This randomized phase III trial studies radiation therapy and cisplatin wit...
A Single-Arm Phase II Clinical Study of Docetaxel Combined With Nimotuzumab and Pucotenlimab as Second-Line and Beyond Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
PHASE2
This study is a single-arm Phase II trial designed to evaluate the efficacy...